Skip to Main content Skip to Navigation
Journal articles

Editorial. SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes?

Fabrice Bonnet 1 André J Scheen 2
1 Foie, métabolismes et cancer
2 Service de Diabétologie, Nutrition et Maladies métaboliques et Unité de Pharmacologie clinique
Document type :
Journal articles
Complete list of metadata
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01134740
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Tuesday, March 24, 2015 - 11:19:30 AM
Last modification on : Friday, December 10, 2021 - 4:08:12 PM

Links full text

openaccess

Identifiers

Collections

UNIV-RENNES1 | BIOSIT | NUMECAN | UR1-UFR-SVE | UNIV-RENNES | UR1-BIO-SA

Citation

Fabrice Bonnet, André J Scheen. Editorial. SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes?. Diabetes and Metabolism, Elsevier Masson, 2014, 40 (6 Suppl 1), pp.S1-3. ⟨10.1016/S1262-3636(14)72688-6⟩. ⟨hal-01134740⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Les métriques sont temporairement indisponibles